| # | Drug | Count |
|---|---|---|
| 0 | RIBAVIRIN | 2238 |
| 1 | SOFOSBUVIR | 1736 |
| 2 | LEDIPASVIR AND SOFOSBUVIR | 887 |
| 3 | OXYCODONE HYDROCHLORIDE | 702 |
| 4 | TACROLIMUS | 599 |
| 5 | MYCOPHENOLATE MOFETIL | 451 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 441 |
| 7 | TACROLIMUS OINTMENT 0.1% | 441 |
| 8 | VELPATASVIR AND SOFOSBUVIR | 413 |
| 9 | PREDNISONE | 400 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SOFOSBUVIR | 1736 | 0.0885 |
| 1 | SOFOSBUVIR, VELPATASVIR, AND VOXILAPREVIR | 91 | 0.0838 |
| 2 | LEDIPASVIR AND SOFOSBUVIR | 887 | 0.0464 |
| 3 | RIBAVIRIN | 2238 | 0.0350 |
| 4 | AMYL NITRITE | 2 | 0.0333 |
| 5 | ELBASVIR AND GRAZOPREVIR | 137 | 0.0322 |
| 6 | VELPATASVIR AND SOFOSBUVIR | 413 | 0.0322 |
| 7 | METHAMPHETAMINE HYDROCHLORIDE | 16 | 0.0148 |
| 8 | TAFASITAMAB-CXIX | 12 | 0.0132 |
| 9 | RALTEGRAVIR | 62 | 0.0118 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 3050 | 0.0582 |
| 1 | Hepatitis C Virus NS5A Inhibitor [EPC] | 1565 | 0.0326 |
| 2 | Nucleoside Analog Antiviral [EPC] | 2251 | 0.0263 |
| 3 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 305 | 0.0187 |
| 4 | Human Antihemophilic Factor [EPC] | 2 | 0.0130 |
| 5 | Vasopressin Receptor Agonist [EPC] | 4 | 0.0121 |
| 6 | Interleukin-5 Antagonist [EPC] | 5 | 0.0073 |
| 7 | Human Blood Coagulation Factor [EPC] | 5 | 0.0061 |
| 8 | Benzodiazepine Antagonist [EPC] | 5 | 0.0056 |
| 9 | CCR5 Co-receptor Antagonist [EPC] | 12 | 0.0052 |